These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 38203940)

  • 1. Hydrogels in Ophthalmology: Novel Strategies for Overcoming Therapeutic Challenges.
    Wu KY; Akbar D; Giunta M; Kalevar A; Tran SD
    Materials (Basel); 2023 Dec; 17(1):. PubMed ID: 38203940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodegradable Polymer-Based Drug-Delivery Systems for Ocular Diseases.
    Tsung TH; Tsai YC; Lee HP; Chen YH; Lu DW
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suprachoroidal Injection: A Novel Approach for Targeted Drug Delivery.
    Wu KY; Fujioka JK; Gholamian T; Zaharia M; Tran SD
    Pharmaceuticals (Basel); 2023 Sep; 16(9):. PubMed ID: 37765048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrogel-based ocular drug delivery systems: Emerging fabrication strategies, applications, and bench-to-bedside manufacturing considerations.
    Cooper RC; Yang H
    J Control Release; 2019 Jul; 306():29-39. PubMed ID: 31128143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrogels in ophthalmic applications.
    Kirchhof S; Goepferich AM; Brandl FP
    Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):227-38. PubMed ID: 26032290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrogel-based ocular drug delivery systems for hydrophobic drugs.
    Torres-Luna C; Fan X; Domszy R; Hu N; Wang NS; Yang A
    Eur J Pharm Sci; 2020 Nov; 154():105503. PubMed ID: 32745587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Desired properties of polymeric hydrogel vitreous substitute.
    Qu S; Tang Y; Ning Z; Zhou Y; Wu H
    Biomed Pharmacother; 2024 Mar; 172():116154. PubMed ID: 38306844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A New Era in Ocular Therapeutics: Advanced Drug Delivery Systems for Uveitis and Neuro-Ophthalmologic Conditions.
    Wu KY; Tan K; Akbar D; Choulakian MY; Tran SD
    Pharmaceutics; 2023 Jul; 15(7):. PubMed ID: 37514137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal hydrogels for sustained release of therapeutic proteins.
    Ilochonwu BC; Urtti A; Hennink WE; Vermonden T
    J Control Release; 2020 Oct; 326():419-441. PubMed ID: 32717302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of ocular drug delivery systems using molecularly imprinted soft contact lenses.
    Tashakori-Sabzevar F; Mohajeri SA
    Drug Dev Ind Pharm; 2015 May; 41(5):703-13. PubMed ID: 25113431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cationic self-assembled peptide-based molecular hydrogels for extended ocular drug delivery.
    Liu H; Bi X; Wu Y; Pan M; Ma X; Mo L; Wang J; Li X
    Acta Biomater; 2021 Sep; 131():162-171. PubMed ID: 34157453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrogel beads-based nanocomposites in novel drug delivery platforms: Recent trends and developments.
    Amiri M; Khazaeli P; Salehabadi A; Salavati-Niasari M
    Adv Colloid Interface Sci; 2021 Feb; 288():102316. PubMed ID: 33387892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyaluronic acid-based nanocomposite hydrogels for ocular drug delivery applications.
    Widjaja LK; Bora M; Chan PN; Lipik V; Wong TT; Venkatraman SS
    J Biomed Mater Res A; 2014 Sep; 102(9):3056-65. PubMed ID: 24124098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Designing Hydrogels for On-Demand Therapy.
    Oliva N; Conde J; Wang K; Artzi N
    Acc Chem Res; 2017 Apr; 50(4):669-679. PubMed ID: 28301139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Injectable drug depot engineered to release multiple ophthalmic therapeutic agents with precise time profiles for postoperative treatment following ocular surgery.
    Mohammadi M; Patel K; Alaie SP; Shmueli RB; Besirli CG; Larson RG; Green JJ
    Acta Biomater; 2018 Jun; 73():90-102. PubMed ID: 29684622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted Nanotherapies for the Posterior Segment of the Eye: An Integrative Review on Recent Advancements and Challenges.
    Gogoi NR; Marbaniang D; Pal P; Ray S; Mazumder B
    Pharm Nanotechnol; 2022 Nov; 10(4):268-278. PubMed ID: 35946098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current Insights into Targeting Strategies for the Effective Therapy of Diseases of the Posterior Eye Segment.
    Pimple P; Sawant A; Nair S; Sawarkar SP
    Crit Rev Ther Drug Carrier Syst; 2024; 41(2):1-50. PubMed ID: 37938189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioinspired short peptide hydrogel for versatile encapsulation and controlled release of growth factor therapeutics.
    Hiew SH; Wang JK; Koh K; Yang H; Bacha A; Lin J; Yip YS; Vos MIG; Chen L; Sobota RM; Tan NS; Tay CY; Miserez A
    Acta Biomater; 2021 Dec; 136():111-123. PubMed ID: 34551327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-loaded and Blue-ray Filtered Hydrogel as a Potential Intraocular Lens for Cataract Treatment.
    Xiang Y; Zou M; Zhang Y; Jin R; Nie Y
    Pharm Nanotechnol; 2020; 8(4):302-312. PubMed ID: 32167435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly(2-hydroxyethyl methacrylate)/β-cyclodextrin-hyaluronan contact lens with tear protein adsorption resistance and sustained drug delivery for ophthalmic diseases.
    Li R; Guan X; Lin X; Guan P; Zhang X; Rao Z; Du L; Zhao J; Rong J; Zhao J
    Acta Biomater; 2020 Jul; 110():105-118. PubMed ID: 32339710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.